Vanguard Group Inc Dexcom Inc Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding DXCM
# of Institutions
1,075Shares Held
363MCall Options Held
4.1MPut Options Held
3.65M-
Black Rock Inc. New York, NY34.5MShares$2.49 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.18 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.1 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$861 Million0.31% of portfolio
-
Sands Capital Management, LLC Arlington, VA10.6MShares$765 Million3.7% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $27.8B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...